AngioDynamics (NSDQ:ANGO) added two new VPs to its executive team.
The Albany, N.Y.-based device maker named Matthew Kapusta senior VP of business development and Donna Haire senior VP of regulatory, quality, clinical and medical affairs.
Kapusta was most recently VP of strategic planning and financial analysis for Smith & Nephew (NYSE:SNN), the same company that AngioDynamics’ newly minted CEO Joseph DeVivo came from.
Haire came from Philips Healthcare (NYSE:PHG) subsidiary Global Diagnostic X-Ray in Germany, where she served as senior director of quality, regulatory and sustainability.
Haire’s appointment is effective immediately and Kapusta’s role is effective November 15, according to a press release.
Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
- Vascular Dynamics names new president & CEO
Vascular Dynamics Inc., a medical device company developing a new treatment for refractive hypertension, announced that its board of directors has named Robert Stern, age 54, to serve as the company’s president & CEO and a member of its board of directors.
- Boston Scientific names new compliance counsel
Boston Scientific Corp. (NYSE:BSX) appointed Zhongwei Tian compliance counsel for its offices in Shanghai, China.
- Avalere hires FDA policy expert to executive team
Avalere Health is growing its FDA practice with the addition of a leading expert in FDA policy and regulatory affairs, Dr. Gillian Woollett, who will be a vice president at Avalere Health.